Systemic treatment of tumour‐bearing mice with recombinant TRAIL can efficiently kill tumour cells without inducing any toxicity and was suggested to be a promising new avenue for cancer treatment (Ashkenazi et al, 1999; Walczak et al, 1999). This evidence concerns the gene TNFSF10 and neoplasm.